J&J's (JNJ) Janssen Receives FDA Panel Backing for MDR-TB Drug Bedaquiline

Go back to J&J's (JNJ) Janssen Receives FDA Panel Backing for MDR-TB Drug Bedaquiline
Johnson & Johnson (NYSE: JNJ) Delayed: 260.35 -1.73 (0.66%)
Previous Close $262.08    52 Week High $126.07 
Open $260.65    52 Week Low $94.28 
Day High $261.71    P/E 54.13 
Day Low $259.16    EPS $4.81 
Volume 4,998,067